Anti-obesity medications: gastrointestinal adverse events common

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-025-77390-3
中图分类号
学科分类号
摘要
引用
收藏
页码:2 / 2
相关论文
共 50 条
  • [1] Update on Anti-obesity Medications
    Park, Kyung-Hee
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2005, 48 (09): : 896 - 903
  • [2] A 10-Year Nationwide Pharmacovigilance Assessment on Anti-Obesity Medications and Factors Associated with Serious Adverse Events
    Choi, Yeo Jin
    Chung, Eun Kyoung
    Shin, Sooyoung
    FASEB JOURNAL, 2022, 36
  • [3] An algorithm for the use of anti-obesity medications
    Dehghani, Fereshteh
    Ahmadi, Mitra Ali
    Hefner, Marleigh
    Kudchadkar, Gaurav
    Najam, Wasiuddin
    Nateqi, Masoud
    Siddik, Md Abu Bakkar
    Booe, Holli
    Dhurandhar, Nikhil V.
    NUTRITION & DIABETES, 2024, 14 (01)
  • [4] Second Generation Anti-Obesity Medications
    Chimatapu, Sri Nikhita
    Mittelman, Steven D.
    Singhal, Vibha
    CURRENT PEDIATRICS REPORTS, 2024, 12 (04) : 138 - 146
  • [5] The Effective Use of Anti-obesity Medications
    Schmitz, Sarah H.
    Aronne, Louis J.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2023, 52 (04) : 661 - 680
  • [6] Tolerability and Safety of the New Anti-Obesity Medications
    Hainer, Vojtech
    Aldhoon-Hainerova, Irena
    DRUG SAFETY, 2014, 37 (09) : 693 - 702
  • [8] Tolerability and Safety of the New Anti-Obesity Medications
    Vojtech Hainer
    Irena Aldhoon-Hainerová
    Drug Safety, 2014, 37 : 693 - 702
  • [9] Effects of Anti-Obesity Medications in RA Patients
    Dente, Elizabeth
    Kellner, David
    Tran, Vincent
    Welsh, Travis
    Tran, Victor
    Saha, Angshuman
    Brook, Jenny
    Elashoff, David
    Ranganath, Veena
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4543 - 4544
  • [10] The impact of approved anti-obesity medications on osteoarthritis
    Baser, Onur
    Rodchenko, Katarzyna
    Vivier, Elizabeth
    Baser, Isabel
    Lu, Yuanqing
    Mohamed, Munira
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (11) : 1565 - 1573